{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:44:38Z","timestamp":1793159078145,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"King Saud University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["MED-P-S-02-2025-11"],"award-info":[{"award-number":["MED-P-S-02-2025-11"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejmech.2025.117752","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:56:17Z","timestamp":1746795377000},"page":"117752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Rationally designed Pyrazolo[1,5-a]pyrimidines as dual inhibitors of CA IX\/XII and CDK6: A novel approach for NSCLC treatment"],"prefix":"10.1016","volume":"293","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-1788","authenticated-orcid":false,"given":"Mahmoud S.","family":"Elkotamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam A.","family":"Elkelesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania S.M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessam M.","family":"El-Refaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Almehizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Naglah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem A.","family":"Ghabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rofaida","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2025.117752_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.30574\/wjbphs.2024.17.2.0046","article-title":"Reviewing the progress of cancer research in the USA","volume":"17","author":"Okoduwa","year":"2024","journal-title":"World Journal of Biology Pharmacy and Health Sciences"},{"key":"10.1016\/j.ejmech.2025.117752_bib2","first-page":"139","article-title":"An overview of cancer treatment modalities","volume":"1","author":"Abbas","year":"2018","journal-title":"Neoplasm"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117752_bib3","doi-asserted-by":"crossref","first-page":"16852","DOI":"10.3390\/molecules200916852","article-title":"Heterocyclic anticancer compounds: recent advances and the paradigm shift towards the use of nanomedicine's tool box","volume":"20","author":"Martins","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117752_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.117752_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108247","article-title":"Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profiles","author":"Elkotamy","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117752_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/14756366.2021.2015344","article-title":"2-Arylquinolines as novel anticancer agents with dual EGFR\/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights","volume":"37","author":"Elbadawi","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117752_bib7","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1080\/14756366.2022.2104841","article-title":"Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer","volume":"37","author":"Abdelsalam","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117752_bib8","doi-asserted-by":"crossref","first-page":"115525","DOI":"10.1016\/j.bmc.2020.115525","article-title":"Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA\/B) inhibitors: synthesis, biological evaluation and in silico insights","volume":"28","author":"Al-Sanea","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117752_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2025.2475233","article-title":"Design, synthesis and biological evaluation of pyrazolo [3, 4-b] pyridine derivatives as dual CDK2\/PIM1 inhibitors with potent anti-cancer activity and selectivity","author":"Elkotamy","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.117752_bib10","series-title":"Carbonic Anhydrase IX: Regulation and Role in Cancer, Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications","first-page":"199","author":"Benej","year":"2013"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117752_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117752_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"24","key":"10.1016\/j.ejmech.2025.117752_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI insight"},{"issue":"15","key":"10.1016\/j.ejmech.2025.117752_bib14","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1021\/acs.jmedchem.3c00721","article-title":"1, 5-diaryl-1, 2, 4-triazole ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities","volume":"66","author":"Elsawi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117752_bib15","doi-asserted-by":"crossref","first-page":"112019","DOI":"10.1016\/j.ejmech.2019.112019","article-title":"Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: design, synthesis, and in vitro biological evaluation","volume":"189","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117752_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140462","article-title":"Development of pyrazolo [1, 5-a] pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity","author":"Elkotamy","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117752_bib17","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1093\/nar\/gkaa1002","article-title":"A unified model for the G1\/S cell cycle transition","volume":"48","author":"Hume","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117752_bib18","first-page":"135","article-title":"Roscovitine in cancer and other diseases","volume":"3","author":"Cicenas","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117752_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/ar0201198","article-title":"Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials","volume":"36","author":"Meijer","year":"2003","journal-title":"Acc. Chem. Res."},{"issue":"171","key":"10.1016\/j.ejmech.2025.117752_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0145-2023","article-title":"CDK4\/6 inhibitors in lung cancer: current practice and future directions","volume":"33","author":"Lv","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ejmech.2025.117752_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40265-015-0379-9","article-title":"Palbociclib: first global approval","volume":"75","author":"Dhillon","year":"2015","journal-title":"Drugs"},{"issue":"18","key":"10.1016\/j.ejmech.2025.117752_bib22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","article-title":"Ribociclib as first-line therapy for HR-positive, advanced breast cancer","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117752_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40265-021-01508-y","article-title":"Trilaciclib: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"issue":"9\u201310","key":"10.1016\/j.ejmech.2025.117752_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0014-827X(00)00079-3","article-title":"Studies on aminopyrazoles: antibacterial activity of some novel pyrazolo [1, 5-a] pyrimidines containing sulfonamido moieties","volume":"55","author":"El-Gaby","year":"2000","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejmech.2025.117752_bib25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.molstruc.2016.07.043","article-title":"Reaction of (Chloro carbonyl) phenyl ketene with 5-amino pyrazolones: synthesis, characterization and theoretical studies of 7-hydroxy-6-phenyl-3-(phenyldiazenyl) pyrazolo [1, 5-a] pyrimidine-2, 5 (1H, 4H)-dione derivatives","volume":"1125","author":"Zahedifar","year":"2016","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117752_bib26","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1002\/jhet.2977","article-title":"Synthesis, characterization, solvatochromic properties, and antimicrobial\u2010radical scavenging activities of new diazo dyes derived from pyrazolo [1, 5\u2010a] pyrimidine","volume":"54","author":"\u015eener","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117752_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.dyepig.2018.04.040","article-title":"Anticancer, antimicrobial, and DNA protection analysis of novel 2, 4-dihydroxyquinoline dyes","volume":"157","author":"\u015eener","year":"2018","journal-title":"Dyes Pigments"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117752_bib28","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/acs.jmedchem.8b00625","article-title":"Discovery of \u03b2-adrenergic receptors blocker\u2013carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy","volume":"61","author":"Nocentini","year":"2018","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117752_bib29","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/acs.jmedchem.9b02090","article-title":"Discovery of potent dual-tailed benzenesulfonamide inhibitors of human carbonic anhydrases implicated in glaucoma and in vivo profiling of their intraocular pressure-lowering action","volume":"63","author":"Fares","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117752_bib30","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1080\/14756366.2022.2124409","article-title":"Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII","volume":"37","author":"Al-Warhi","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117752_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/ijms23010461","article-title":"Aromatic sulfonamides including a sulfonic acid tail: new membrane impermeant carbonic anhydrase inhibitors for targeting selectively the cancer-associated isoforms","volume":"23","author":"Giovannuzzi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117752_bib32","article-title":"Analysis of cell viability by the MTT assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ejmech.2025.117752_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107766","article-title":"Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction","volume":"153","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117752_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.cdd.4402257","article-title":"R-Roscovitine simultaneously targets both the p53 and NF-\u03baB pathways and causes potentiation of apoptosis: implications in cancer therapy","volume":"15","author":"Dey","year":"2008","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117752_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1269\/jrr.08024","article-title":"Enhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cells","volume":"49","author":"Zhang","year":"2008","journal-title":"J. Radiat. Res."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117752_bib36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajpath.2017.01.009","article-title":"Evidence, mechanism, and clinical relevance of the transdifferentiation from lung adenocarcinoma to squamous cell carcinoma","volume":"187","author":"Hou","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117752_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.10699","article-title":"Cell cycle checkpoints and their impact on anticancer therapeutic strategies","volume":"91","author":"Eastman","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117752_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrd2907","article-title":"Cell cycle kinases as therapeutic targets for cancer","volume":"8","author":"Lapenna","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117752_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70009","article-title":"Molecular docking, DFT and antiproliferative properties of 4\u2010(3, 4\u2010dimethoxyphenyl)\u2212 3\u2010(4\u2010methoxyphenyl)\u2212 1\u2010phenyl\u20101H\u2010pyrazolo [3, 4\u2010b] pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency","volume":"85","author":"Binjubair","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117752_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41577-020-0300-y","article-title":"Immunomodulation by anticancer cell cycle inhibitors","volume":"20","author":"Petroni","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.117752_bib41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopha.2017.05.128","article-title":"Umbelliferone arrest cell cycle at G0\/G1 phase and induces apoptosis in human oral carcinoma (KB) cells possibly via oxidative DNA damage","volume":"92","author":"Vijayalakshmi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117752_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/biomedicines12020297","article-title":"Unraveling the potential of ALK-targeted therapies in non-small cell lung cancer: comprehensive insights and future directions","volume":"12","author":"Parvaresh","year":"2024","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117752_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","article-title":"Understanding apoptosis and apoptotic pathways targeted cancer therapeutics","volume":"9","author":"Jan","year":"2019","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2025.117752_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140579","article-title":"Exploring antitumor activity of novel imidazo [2, 1-b] thiazole and imidazo [1, 2-a] pyridine derivatives on MDA-MB-231 cell line: targeting VEGFR-2 enzyme with computational insight","volume":"1322","author":"Elgohary","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117752_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/clo.2009.0028","article-title":"Serum-starved apoptotic fibroblasts reduce blastocyst production but enable development to term after SCNT in cattle","volume":"11","author":"Miranda","year":"2009","journal-title":"Clon Stem Cell"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117752_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3934\/publichealth.2017.2.127","article-title":"The role of the WI-38 cell strain in saving lives and reducing morbidity","volume":"4","author":"Olshansky","year":"2017","journal-title":"AIMS Public Health"},{"issue":"13","key":"10.1016\/j.ejmech.2025.117752_bib47","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1021\/jm500631u","article-title":"Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid\u2013camptothecin combination chemotherapy","volume":"57","author":"Vineberg","year":"2014","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117752_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/cells8040321","article-title":"Updates on the CDK4\/6 inhibitory strategy and combinations in breast cancer","volume":"8","author":"Sobhani","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117752_bib49","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/molecules25092031","article-title":"Synthesis, biological evaluation and in silico studies of certain oxindole\u2013indole conjugates as anticancer CDK inhibitors","volume":"25","author":"Al-Warhi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117752_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117158","article-title":"Design, synthesis, and evaluation of novel benzofuran and pyrazole-based derivatives as dual AChE\/BuChE inhibitors with antioxidant properties for Alzheimer's disease management","volume":"283","author":"Elkotamy","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117752_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41570-018-0018-6","article-title":"Metal\u2013ligand interactions in drug design","volume":"2","author":"Riccardi","year":"2018","journal-title":"Nat. Rev. Chem"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117752_bib52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/1574893615666191219094216","article-title":"Relevance of molecular docking studies in drug designing","volume":"15","author":"Jakhar","year":"2020","journal-title":"Curr. Bioinf."},{"key":"10.1016\/j.ejmech.2025.117752_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bpc.2015.05.009","article-title":"Intrinsic thermodynamics of 4-substituted-2, 3, 5, 6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry","volume":"205","author":"Zubrien\u0117","year":"2015","journal-title":"Biophys. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117752_bib54","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117752_bib55","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1535-7163.MCT-16-0300","article-title":"Spectrum and degree of CDK drug interactions predicts clinical performance","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117752_bib56","doi-asserted-by":"crossref","first-page":"20438","DOI":"10.1021\/acs.jmedchem.4c01894","article-title":"4-(Pyrazolyl) benzenesulfonamide ureas as carbonic anhydrases inhibitors and hypoxia-mediated chemo-sensitizing agents in colorectal cancer cells","volume":"67","author":"Eldehna","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117752_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112897","article-title":"Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: synthesis, biological and molecular dynamics analysis","volume":"209","author":"Abdelrahman","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117752_bib58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejmech.2016.01.001","article-title":"Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents","volume":"109","author":"Alafeefy","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117752_bib59","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.bmc.2017.02.037","article-title":"Synthesis of bulky-tailed sulfonamides incorporating pyrido [2, 3-d][1, 2, 4] triazolo [4, 3-a] pyrimidin-1 (5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects","volume":"25","author":"Fares","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117752_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272362","article-title":"Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2, 4-diones targeting VEGFR-2 and apoptosis pathway","volume":"17","author":"Taghour","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117752_bib61","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14756366.2022.2070744","article-title":"Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies","volume":"37","author":"Yousef","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117752_bib62","doi-asserted-by":"crossref","first-page":"115538","DOI":"10.1016\/j.ejmech.2023.115538","article-title":"Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer","volume":"258","author":"Eldehna","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"26","key":"10.1016\/j.ejmech.2025.117752_bib63","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9153","article-title":"Efficacy of the combination of MEK and CDK4\/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117752_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139170","article-title":"Sulfonamide-Pyrazole derivatives as next-generation Cyclooxygenase-2 enzyme inhibitors: from molecular design to in vivo efficacy","volume":"293","author":"Elgohary","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"W1","key":"10.1016\/j.ejmech.2025.117752_bib65","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117752_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137554","article-title":"Spiro-fused indoline-quinazoline hybrids as smart bombs against TNF-\u03b1-mediated inflammation","volume":"283","author":"Elkotamy","year":"2024","journal-title":"Int. J. Biol. Macromol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:16:45Z","timestamp":1748405805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425005173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":66,"alternative-id":["S0223523425005173"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117752","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationally designed Pyrazolo[1,5-a]pyrimidines as dual inhibitors of CA IX\/XII and CDK6: A novel approach for NSCLC treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117752"}}